目次

Table of Contents

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Inactivated vaccine - Market size and forecast 2020-2025
Live attenuated vaccine - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Cadila Healthcare Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd.
GlaxoSmithKline Plc
LG Corp.
MassBiologics
Meiji Holdings Co. Ltd.
Merck and Co. Inc.
Mitsubishi Tanabe Pharma Corp.
Sanofi SA

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Inactivated vaccine - Market size and forecast 2020-2025 ($ million)
24: Inactivated vaccine - Year-over-year growth 2020-2025 (%)
25: Live attenuated vaccine - Market size and forecast 2020-2025 ($ million)
26: Live attenuated vaccine - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Cadila Healthcare Ltd. - Overview
48: Cadila Healthcare Ltd. - Business segments
49: Cadila Healthcare Ltd. - Key offerings
50: Cadila Healthcare Ltd. - Key customers
51: Cadila Healthcare Ltd. - Segment focus
52: CSL Ltd. - Overview
53: CSL Ltd. - Business segments
54: CSL Ltd. - Key offerings
55: CSL Ltd. - Key customers
56: CSL Ltd. - Segment focus
57: Daiichi Sankyo Co. Ltd. - Overview
58: Daiichi Sankyo Co. Ltd. - Business segments
59: Daiichi Sankyo Co. Ltd. - Key offerings
60: Daiichi Sankyo Co. Ltd. - Key customers
61: Daiichi Sankyo Co. Ltd. - Segment focus
62: GlaxoSmithKline Plc - Overview
63: GlaxoSmithKline Plc - Business segments
64: GlaxoSmithKline Plc - Key offerings
65: GlaxoSmithKline Plc - Key customers
66: GlaxoSmithKline Plc - Segment focus
67: LG Corp. - Overview
68: LG Corp. - Business segments
69: LG Corp. - Key offerings
70: LG Corp. - Key customers
71: LG Corp. - Segment focus
72: MassBiologics - Overview
73: MassBiologics - Product and service
74: MassBiologics - Key offerings
75: MassBiologics - Key customers
76: MassBiologics - Segment focus
77: Meiji Holdings Co. Ltd. - Overview
78: Meiji Holdings Co. Ltd. - Business segments
79: Meiji Holdings Co. Ltd. - Key offerings
80: Meiji Holdings Co. Ltd. - Key customers
81: Meiji Holdings Co. Ltd. - Segment focus
82: Merck and Co. Inc. - Overview
83: Merck and Co. Inc. - Business segments
84: Merck and Co. Inc. - Key offerings
85: Merck and Co. Inc. - Key customers
86: Merck and Co. Inc. - Segment focus
87: Mitsubishi Tanabe Pharma Corp. - Overview
88: Mitsubishi Tanabe Pharma Corp. - Business segments
89: Mitsubishi Tanabe Pharma Corp. - Key offerings
90: Mitsubishi Tanabe Pharma Corp. - Key customers
91: Mitsubishi Tanabe Pharma Corp. - Segment focus
92: Sanofi SA - Overview
93: Sanofi SA - Business segments
94: Sanofi SA - Key offerings
95: Sanofi SA - Key customers
96: Sanofi SA - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations